Dr Robert Coleman is Chief Scientific Officer at The US Oncology Network, one of the largest networks of integrated, community-based oncology practices in the US. Dr Coleman leads one of the largest research programs in the country drawing from a network of more than 1,000 experienced investigators and dedicated clinical staff who specialise in oncology clinical trials. Dr Coleman’s work has been published extensively in more than 600 peer-reviewed articles, book chapters and textbooks, including over 300 peer-reviewed articles. He is the current President of the International Gynaecologic Cancer Society and has served as President of the Society of Gynaecologic Oncology. He serves on the Board of Directors for GOG-Foundation as is Co-Director for GOG-Partners.

Dr Susana Banerjee, is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit at The Royal Marsden NHS Foundation Trust and Reader in Women’s Cancers at the Institute of Cancer Research, London, UK. Dr Banerjee has been involved in international specialist groups including the European Organisation for Research and Treatment of Cancer (EORTC) Executive Steering Committee for Gynaecological Cancers, and European Society of Medical Oncology (ESMO) Scientific Committee. She has led national and international trials, authored over 120 peer-reviewed articles and currently serves on the European Society of Medical Oncology (ESMO) Executive Board. Dr Banerjee graduated from Cambridge University and gained a PhD from the Institute of Cancer Research.

Dr Thomas Herzog is the Deputy Director of the University of Cincinnati Cancer Center and an endowed professor of Obstetrics and Gynaecology at the UC College of Medicine. Dr Herzog is a National Institutes of Health and American Cancer Society funded researcher with over 300 published manuscripts. Dr Herzog has served on the board of directors or leadership council of the Society of Gynaecologic Oncology, the Foundation for Women’s Cancer, American College of Surgeons Board of Governors, American Board of Obstetrics and Gynaecology, GOG Foundation and the International Gynaecologic Cancer Society.

Dr Josep Tabernero MD PhD is Head of the Medical Oncology Department at Vall d’Hebron University Hospital and Director of the Vall d’Hebron Institute of Oncology in Barcelona (Spain) and Professor of Medicine at the Universitat de Vic/UCC.

He has been Principal Investigator of several Phase I pharmacodynamic studies with tumour-directed targeted therapies and immune-based therapies. His research has been focused on the development of molecular targeted therapies and the identification of molecular biomarkers of response/ resistance, and it is formed by both clinical and translational researchers, working in various thematic areas (sophisticated preclinical models, liquid biopsies, microbiome).

Dr Tabernero serves on the Editorial Boards of various top tier journals including Cancer Discovery, Cancer Treatment Reviews, and Nature Reviews Clinical Oncology. He has (co) authored approximately 600 peer-reviewed papers with an H-Index of 122.  He was the President (2018 – 2019) of the European Society for Medical Oncology´s (ESMO). He is also member of the American Association for Cancer Research (AACR), the American Society of Clinical Oncology (ASCO). He has also been a member of the Educational and Scientific Committees of ESMO, ASCO, AACR, AACR/NCI/EORTC, ASCO Gastrointestinal, TAT and ESMO-GI meetings.

Based in Milan, Prof. Colombo is the Director of the Gynaecologic Oncology Program at the European Institute of Oncology in Milan  (IEO). She has served as the Chair of the Division of Medical Gynaecologic Oncology and Director of the Ovarian Cancer Centre of the IEO since 2014.

Prof. Colombo has participated as principal investigator and coordinator of Italian centres for several international clinical trials. She has authored ≥400 papers published in peer-reviewed journals and has served on the Editorial Boards of several, including the Journal of Clinical Oncology, Annals of Oncology, and the International Journal of Gynaecological Oncology, the latter as Senior Editor. She was the Chair of the ESMO–ESGO–ESTRO Consensus Conference in endometrial cancer in 2015, and of the ESGO Consensus Conference in ovarian cancer in 2018. She is a member of several professional organizations, including the SGO, ASCO and IGCS. In addition, Prof. Colombo previously held the positions of President of the ESGO and chair of ENGOT.  In 2020, Prof. Colombo received the IGCS Lifetime Achievement Award and in 2023 the ESGO Lifetime Achievement Award in recognition of her work in gynaecological oncology. In 2025 she received the International Charitè-Mayo award for outstanding engagement in woman Cancer.